Pfizer Inc

(

PFE

) pushed the Drugs industry higher today making it today's featured drugs winner. The industry as a whole closed the day up 3.2%. By the end of trading, Pfizer Inc rose 64 cents (3.5%) to $19.09 on average volume. Throughout the day, 40 million shares of Pfizer Inc exchanged hands as compared to its average daily volume of 47.1 million shares. The stock ranged in a price between $18.77-$19.10 after having opened the day at $18.81 as compared to the previous trading day's close of $18.45. Other companies within the Drugs industry that increased today were:

AVANIR Pharmaceuticals

(

AVNR

), up 27.5%,

Amicus Therapeutics Inc

(

FOLD

), up 20.5%,

Rosetta Genomics

(

ROSG

), up 18.2%, and

Rosetta Genomics

(

ROSGD

), up 18.2%.

Pfizer Inc., a biopharmaceutical company, offers prescription medicines for humans and animals worldwide. Pfizer Inc has a market cap of $145.28 billion and is part of the

health care

sector. The company has a P/E ratio of 14.5, above the average drugs industry P/E ratio of 13 and below the S&P 500 P/E ratio of 17.7. Shares are up 5.4% year to date as of the close of trading on Friday.

TheStreet Ratings rates Pfizer as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, attractive valuation levels and compelling growth in net income. We feel these strengths outweigh the fact that the company shows weak operating cash flow.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the drugs industry could consider

SPDR S&P Pharmaceuticals ETF

(

XPH

) while those bearish on the drugs industry could consider

ProShares UltraShort Nasdaq Biotech

(

BIS

).

null